Corporate Information

Collaboration with 3A grade hospitals in the quick delivery of clinic reports in genetic testing2017/07/01

The development of sequencing technology has led to a dramatic increase in DNA data, which has made a huge breakthrough in biological technology and medicine. However, at the same time, these vast numbers of data analysis, storage, and compression are increasingly raised as a new problem. Meanwhile, the extensively uses of clinical testing and assisted diagnostic technology have tightly coupled clinicians with these new technologies.


Recently, Shanghai CelLoud Co., Ltd.(hereinafter referred to as "CelLoud") achieved strategic cooperations with serials of 3A grade hospitals in the quick delivery of clinical reports in genetic testing including Peking Union Medical College Hospital Ruijin Hospital Affiliated to Medical School of Shanghai Jiaotong University Zhongshan Hospital Affiliated to Fudan University, Shanghai Jiaotong University Affiliated Children's Hospital, Capital Medical University Xuanwu Hospital, Beijing Ditan Hospital, China-japan Friendship Hospital, Capital Medical University Affiliated Beijing Anzhen Hospital, Capital Medical University Affiliated Beijing Ditan Hospital, Beijing Hospital, the Fourth People's Hospital of Qinghai Province, Qilu Hospital of Shandong University, China Medical University First Affiliated Hospital, etc. The application of CelLoud in clinic, will reduce the threshold of data analysis, improve the interpretation efficiency, and shorten the feedback cycle of gene detection reports.


CelLoud platform is the product of the perfect combination of biomedical informatics technology and cloud computing technology. One key operation could complete the automation bioinformatics analysis from raw data to reports. The sample quantity more than 2000 can be processed in parallel, and the detection reports are generated at very high speed at ‘minute level’.


Genetic data interpretation is a bottleneck in industry. The different interpretation systems was used in different companies may lead to the difference of the final data results. Under the background of precision medical, more and more genetic testing result will assist the doctor in disease warning, installment, typing, personalized medicine diagnosis. Only when the specific requirements of the clinician and patient are combined, the expert agreement could be established in different level, and truly meet requirements of national regulatory and clinical practice.

... Back